| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.66B | 1.67B | 1.68B | 1.61B | 1.34B | 1.19B |
| Gross Profit | 332.40M | 333.90M | 1.28B | 576.70M | 492.30M | 398.50M |
| EBITDA | 378.90M | 378.30M | 390.60M | 402.10M | 392.00M | 324.30M |
| Net Income | 162.70M | 191.20M | 183.60M | 224.70M | 234.60M | 173.60M |
Balance Sheet | ||||||
| Total Assets | 2.58B | 2.65B | 2.71B | 2.78B | 1.86B | 1.74B |
| Cash, Cash Equivalents and Short-Term Investments | 303.20M | 334.20M | 359.70M | 328.90M | 274.60M | 246.20M |
| Total Debt | 1.05B | 1.03B | 1.12B | 1.08B | 465.20M | 509.10M |
| Total Liabilities | 1.45B | 1.44B | 1.55B | 1.62B | 853.20M | 889.10M |
| Stockholders Equity | 1.14B | 1.21B | 1.16B | 1.17B | 1.01B | 851.30M |
Cash Flow | ||||||
| Free Cash Flow | 248.30M | 238.50M | 193.20M | 113.70M | 204.20M | 202.40M |
| Operating Cash Flow | 317.20M | 312.80M | 298.60M | 231.20M | 268.30M | 252.00M |
| Investing Cash Flow | -85.90M | -65.30M | -95.70M | -576.60M | -62.10M | -52.50M |
| Financing Cash Flow | -174.10M | -215.00M | -219.20M | 362.20M | -204.80M | -143.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £6.08B | 26.36 | 23.79% | 1.32% | -0.32% | -3.96% | |
75 Outperform | £7.36B | 24.05 | 17.68% | 1.28% | -1.97% | 40.55% | |
72 Outperform | £4.90B | 30.12 | 14.19% | 2.50% | 0.10% | -15.33% | |
66 Neutral | £2.69B | 27.61 | 16.97% | 2.07% | 1.93% | -15.07% | |
66 Neutral | £7.43B | 27.14 | 12.85% | 1.97% | -6.93% | 18.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | £6.93B | 22.38 | 10.69% | 1.16% | -0.38% | ― |
Spirax Group plc has announced the completion of several DRIP (Dividend Reinvestment Plan) transactions involving key managerial personnel. These transactions, conducted on the Main Market of the London Stock Exchange, involved the award of ordinary shares following the interim dividend payment. The transactions highlight the company’s ongoing commitment to rewarding its leadership team and maintaining transparency in its financial dealings.
Spirax Group PLC reported organic revenue growth and improved profit margins for the ten months ending October 2025, despite challenging global industrial production conditions. The company saw strong sales growth in its Electric Thermal Solutions and Watson-Marlow divisions, driven by operational improvements and increased demand in sectors like biopharmaceuticals and semiconductors. Spirax remains on track to achieve annualized savings from restructuring efforts, which are being reinvested into growth priorities. The company’s financial position has strengthened, with reduced net borrowings and a stable outlook for continued organic growth in revenues and operating profit margins.
Spirax Group plc has announced transactions involving its senior management under the company’s employee share schemes. The transactions, which include the acquisition of partnership shares and the award of matching shares, involve key figures such as the Group CEO, HR Director, Sustainability Director, and Managing Director of ETS. These transactions, conducted on the London Stock Exchange, reflect the company’s ongoing commitment to aligning managerial interests with shareholder value through its Share Incentive Plan.
Spirax Group has announced the appointment of Andrew Kemp as an Independent Non-Executive Board Director and member of the Audit Committee, effective from November 1, 2025. This appointment is part of the company’s succession planning to support its ‘Together for Growth Strategy.’ Andrew Kemp, who will succeed Kevin Thompson as Chair of the Audit Committee in April 2026, brings extensive experience from his roles in various companies and as a former PwC executive. This strategic move is expected to bolster Spirax Group’s governance and support its ongoing growth and development.
Spirax Group plc has announced a series of transactions involving key managerial personnel under the company’s employee share schemes. The transactions, which include the acquisition of Partnership Shares and the award of Matching Shares, were conducted on the London Stock Exchange and are part of the company’s Share Incentive Plan. These transactions reflect the company’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially impacting stakeholder confidence and market perception.
Spirax Group plc, a company involved in the engineering sector, has announced transactions related to its employee share schemes. The announcement details acquisitions of shares by key personnel under the company’s Share Incentive Plan, reflecting ongoing commitment to employee engagement and retention strategies.